This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Diabetes, Metabolic Syndrome And Cardiovascular Disease

Table 6.1: Value Market Shares of Animal, Human and Modern Insulin, 1995-2010 101

Table 6.2: Worldwide Insulin Sales, 2008-2016 102

Table 6.3: Worldwide Insulin Sales and Market Share by World Region, 2011 102

Table 6.4: Estimated U.S. Retail Insulin Sales, 2011-2016 102

Table 6.5: Worldwide Insulin Sales and Market Share by Company, 2011 103

Table 6.6: U.S. Insulin Sales and Market Share by Company, 2011 103

Table 6.7: Insulins on the U.S. Market 105

Table 6.8: Pharmacokinetics of Therapeutic Insulins on the U.S. Market 106

Table 6.9: Pharmacokinetics of Short-Acting Insulins 108

Table 6.10: Pharmacokinetics of Rapid-Acting Insulins 108

Table 6.11: Pharmacokinetics of Intermediate-Acting Insulins 110

Table 6.12: Pharmacokinetics of Long-Acting Insulins 110

Table 6.13: Pharmacokinetics of Insulin Mixtures 112

Table 6.14: Status of Inhaled Insulin Products, 2011 117

Table 6.15: Key Drivers of the Type 2 Diabetes Insulin Market, 2012 122

Table 6.16: A Comparison of Existing Insulin Delivery Devices 123

Table 6.17: Insulin Pens 125

Table 6.18: Estimated Worldwide Demand for Insulin Injector Pens by Volume, 2012-2016 127

Table 6.19: Injection Aids 128

Table 6.20: Jet Injectors 130

Table 6.21: Control Averages by Treatment 131

Table 6.22: Reduced Risk for Various Diseases When Blood Glucose is Near Normal 131

Table 6.23: Leading Insulin Pump Manufacturers 132

Table 6.24: Comparison of Current External Insulin Pumps on the Market 132

Table 6.25: Insulin Infusion Sets 137

Table 6.26: Worldwide Insulin Pump Market, 2009-2016 141

Table 7.1: Advantages and Disadvantages of Newer Type 2 Diabetes Therapies 146

Table 7.2: Cells of the Pancreas 148

Table 7.3: Lipoprotein Risk Levels and Treatment Goals in Adult Patients with Diabetes 154

Table 7.4: Agents for Lowering Lipid Levels in Patients with Dyslipidemia 155

Table 7.5: Suggested Pharmacological Treatment Agents for Hypertension in Patients with Diabetes 156

Table 8.1: Criteria for the Diagnosis of Diabetes 159

8 of 9

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 17,976.31 +263.65 1.49%
S&P 500 2,086.24 +25.22 1.22%
NASDAQ 4,947.4410 +56.2220 1.15%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs